Found 7 matching trials
A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy PHASE2 This study aims to evaluate the efficacy and safety of adebrelimab consolid...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD PHASE2 This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Show More Learn More & Join Trial
Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma PHASE3 Radiotherapy (RT) is an important option for patients with limited stage FL...
Show More Learn More & Join Trial
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma NA This is an open-label, single-arm, multi-center Phase II clinical trial eva...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
"Sandwich" Chemotherapy With Radiotherapy in Newly Diagnosed, Stage IE to IIE, ENKTL PHASE2 A phase 2 study was conducted of "sandwich" protocols, with earlier RT afte...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma PHASE3 The most common option of radiotherapy for patients with limited-stage DLBC...
Show More Learn More & Join Trial
The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma PHASE3 The standard treatment approach for patients with stage III-IV DLBCL is com...
Show More Learn More & Join Trial